Dipal Doshi, CEO: Entrada Therapeutics TRDA Sell · Filed 24/07/16

Trade details

Type: Insider sale
Amount: $28,496
Shares · price: 1,600 sh · $17.81 a share
Held after: 334,475 sh
Stock: Entrada Therapeutics TRDA
Person: Dipal DoshiCEO
Trade date: 24/07/15
Filed: 24/07/16
Days to filing: 1 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/15~24/08/14

Dipal Doshi's recent trades

Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$5,400
300 sh
$5,400
Filed 24/07/16
Traded 24/07/12
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$16.2K
1,000 sh
$16.2K
Filed 24/06/14
Traded 24/06/13
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$27K
1,800 sh
$27K
Filed 24/05/20
Traded 24/05/16
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$18.1K
1,200 sh
$18.1K
Filed 24/05/20
Traded 24/05/17
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$15K
1,000 sh
$15K
Filed 24/02/20
Traded 24/02/15

Dipal Doshi, CEO — sold $28.5K of Entrada Therapeutics TRDA · 0.5% of holdings · 10b5-1 plan | Whalegun